[1]
Marcellusi, A., Bini, C., Rotundo, M.A., Cultrera, R. and Mennini, F.S. 2020. Cost-utility of dalbavancin in patients with non-severe ABSSSI in Italy. Global and Regional Health Technology Assessment. 7, 1 (Nov. 2020), 92–100. DOI:https://doi.org/10.33393/grhta.2020.2138.